Larissa A. Meyer

Larissa A. Meyer is an Associate Professor in the Department of Gynecologic Oncology and Reproductive Medicine at The University of Texas MD Anderson Cancer Center. Her research focuses on gynecologic cancers, particularly ovarian cancer and leiomyosarcoma, with an emphasis on surgical outcomes, enhanced recovery pathways, and cancer management. Her recent work includes phase I trials combining gemcitabine and nab-sirolimus in advanced soft-tissue sarcomas with TSC1/2 alterations, real-world outcomes of doxorubicin plus trabectedin in leiomyosarcoma, and immune checkpoint blockade in advanced disease. She also investigates barriers to clinical trial enrollment and has published on PPP2R1A mutations portending improved survival after cancer immunotherapy in Nature. Her research integrates translational oncology with outcomes research to advance cancer care.